{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:08:47Z","timestamp":1794341327871,"version":"4.9.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006314","name":"Biogen-Idec","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006314","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Red Bull"},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the European Union"},{"name":"FWF \u00d6sterreichischer Fond zur Wissenschaftsf\u00f6rderung"},{"DOI":"10.13039\/501100007148","name":"Bundesministerium f\u00fcr Wissenschaft und Forschung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007148","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jubil\u00e4umsfond der \u00d6strerreichischen Nationalbank"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.seizure.2016.11.001","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T13:46:14Z","timestamp":1479131174000},"page":"65-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":214,"special_numbering":"C","title":["25 years of advances in the definition, classification and treatment of status epilepticus"],"prefix":"10.1016","volume":"44","author":[{"given":"Eugen","family":"Trinka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetta","family":"K\u00e4lvi\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"June (6)","key":"10.1016\/j.seizure.2016.11.001_bib0005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","article-title":"Status epilepticus in adults","volume":"14","author":"Betjemann","year":"2015","journal-title":"Lancet Neurol"},{"issue":"August","key":"10.1016\/j.seizure.2016.11.001_bib0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2015.04.065","article-title":"Incidence and mortality of super-refractory status epilepticus in adults","volume":"49","author":"Kantanen","year":"2015","journal-title":"Epilepsy Behav: E&B"},{"issue":"April (2)","key":"10.1016\/j.seizure.2016.11.001_bib0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WCO.0000000000000307","article-title":"Recent advances in status epilepticus","volume":"29","author":"Trinka","year":"2016","journal-title":"Curr Opin Neurol"},{"issue":"August","key":"10.1016\/j.seizure.2016.11.001_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2015.05.030","article-title":"The 5th London-Innsbruck colloquium on status epilepticus and acute seizures","volume":"49","author":"Shorvon","year":"2015","journal-title":"Epilepsy Behav: E&B"},{"key":"10.1016\/j.seizure.2016.11.001_bib0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1528-1157.1970.tb03871.x","article-title":"Clinical and electroencephalographical classification of epileptic seizures","volume":"11","author":"Gastaut","year":"1970","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2016.11.001_bib0030","series-title":"Les \u00c7tats de mal \u00c7pileptiques","first-page":"1","article-title":"A propos d'une classification symptomatologique des \u00c7tats de mal \u00c7pileptiques","author":"Gastaut","year":"1967"},{"issue":"Suppl","key":"10.1016\/j.seizure.2016.11.001_bib0035","first-page":"S2","article-title":"Clinical and electroencephalographical classification of epileptic seizures","volume":"10","author":"Gastaut","year":"1969","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2016.11.001_bib0040","first-page":"15","article-title":"Classification of status epilepticus","volume":"vol 34","author":"Gastaut","year":"1983"},{"key":"10.1016\/j.seizure.2016.11.001_bib0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy","volume":"22","year":"1981","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2016.11.001_bib0050","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/jama.1993.03510070076040","article-title":"Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on status epilepticus","volume":"270","year":"1993","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.seizure.2016.11.001_bib0055","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.seizure.2016.11.001_bib0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1157.1999.tb02000.x","article-title":"It's time to revise the definition of status epilepticus","volume":"40","author":"Lowenstein","year":"1999","journal-title":"Epilepsia"},{"issue":"October (10)","key":"10.1016\/j.seizure.2016.11.001_bib0065","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus-report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"issue":"February (2)","key":"10.1016\/j.seizure.2016.11.001_bib0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1528-1167.2009.02297.x","article-title":"Nonconvulsive status epilepticus and coma","volume":"51","author":"Bauer","year":"2010","journal-title":"Epilepsia"},{"issue":"September (Suppl. 4)","key":"10.1016\/j.seizure.2016.11.001_bib0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1528-1167.2012.03622.x","article-title":"Causes of status epilepticus","volume":"53","author":"Trinka","year":"2012","journal-title":"Epilepsia"},{"issue":"August","key":"10.1016\/j.seizure.2016.11.001_bib0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.yebeh.2015.05.005","article-title":"Which EEG patterns in coma are nonconvulsive status epilepticus?","volume":"49","author":"Trinka","year":"2015","journal-title":"Epilepsy Behav: E&B"},{"issue":"February (1)","key":"10.1016\/j.seizure.2016.11.001_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNP.0b013e3182784729","article-title":"American clinical neurophysiology society's standardized critical care EEG terminology: 2012 version","volume":"30","author":"Hirsch","year":"2013","journal-title":"J Clin Neurophys"},{"issue":"September (Suppl. 6)","key":"10.1016\/j.seizure.2016.11.001_bib0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/epi.12270","article-title":"Unified EEG terminology and criteria for nonconvulsive status epilepticus","volume":"54","author":"Beniczky","year":"2013","journal-title":"Epilepsia"},{"issue":"Suppl. 8","key":"10.1016\/j.seizure.2016.11.001_bib0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1528-1167.2007.01345.x","article-title":"EEG criteria for nonconvulsive status epilepticus","volume":"48","author":"Kaplan","year":"2007","journal-title":"Epilepsia"},{"issue":"August","key":"10.1016\/j.seizure.2016.11.001_bib0100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.yebeh.2015.05.007","article-title":"Salzburg consensus criteria for non-convulsive status epilepticus\u2014approach to clinical application","volume":"49","author":"Leitinger","year":"2015","journal-title":"Epilepsy Behav: E&B"},{"issue":"September (10)","key":"10.1016\/j.seizure.2016.11.001_bib0105","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S1474-4422(16)30137-5","article-title":"Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: a retrospective study","volume":"15","author":"Leitinger","year":"2016","journal-title":"Lancet Neurol"},{"issue":"June (1)","key":"10.1016\/j.seizure.2016.11.001_bib0110","article-title":"New ILAE versus previous clinical status epilepticus semiologic classification: analysis of a hospital-based cohort","author":"Rossetti","year":"2016","journal-title":"Epilepsia"},{"issue":"March (3)","key":"10.1016\/j.seizure.2016.11.001_bib0115","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00415-015-7992-0","article-title":"Association of seizure duration and outcome in refractory status epilepticus","volume":"263","author":"Madzar","year":"2016","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2016.11.001_bib0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1157.1994.tb02908.x","article-title":"Determinants of mortality in status epilepticus","volume":"35","author":"Towne","year":"1994","journal-title":"Epilepsia"},{"issue":"April (3)","key":"10.1016\/j.seizure.2016.11.001_bib0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0887-8994(95)00044-G","article-title":"Effect of prehospital treatment on the outcome of status epilepticus in children","volume":"12","author":"Alldredge","year":"1995","journal-title":"Pediatr Neurol"},{"issue":"February (7)","key":"10.1016\/j.seizure.2016.11.001_bib0130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"issue":"October","key":"10.1016\/j.seizure.2016.11.001_bib0135","article-title":"Costs and cost-driving factors for acute treatment of adults with status epilepticus: a multicenter cohort study from Germany","author":"Kortland","year":"2016","journal-title":"Epilepsia"},{"issue":"Suppl. 8","key":"10.1016\/j.seizure.2016.11.001_bib0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1528-1167.2007.01364.x","article-title":"Status epilepticus treatment guidelines","volume":"48","author":"Kalviainen","year":"2007","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2016.11.001_bib0145","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1528-1167.2008.01706_3.x","article-title":"The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on status epilepticus","volume":"49","author":"Shorvon","year":"2008","journal-title":"Epilepsia"},{"issue":"August (1)","key":"10.1016\/j.seizure.2016.11.001_bib0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"issue":"June (3)","key":"10.1016\/j.seizure.2016.11.001_bib0155","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/practneurol-2013-000712","article-title":"A protocol for the inhospital emergency drug management of convulsive status epilepticus in adults","volume":"14","author":"Jones","year":"2014","journal-title":"Practical Neurol"},{"issue":"6","key":"10.1016\/j.seizure.2016.11.001_bib0160","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2125.2007.02931.x","article-title":"Anticonvulsant therapy for status epilepticus","volume":"63","author":"Prasad","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.seizure.2016.11.001_bib0165","doi-asserted-by":"crossref","unstructured":"Prasad M, Krishnan PR, Sequeira R, Al-Roomi K. Anticonvulsant therapy for status epilepticus. The Cochrane database of systematic reviews, 2014. 9 CD003723. PubMed PMID: 25207925.","DOI":"10.1002\/14651858.CD003723.pub3"},{"issue":"August","key":"10.1016\/j.seizure.2016.11.001_bib0170","article-title":"A common reference-based indirect comparison meta-analysis of buccal versus intranasal midazolam for early status epilepticus","author":"Brigo","year":"2015","journal-title":"CNS Drugs"},{"issue":"August","key":"10.1016\/j.seizure.2016.11.001_bib0175","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.yebeh.2015.02.030","article-title":"Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: a systematic review with meta-analysis","volume":"49","author":"Brigo","year":"2015","journal-title":"Epilepsy Behav: E&B"},{"issue":"June (6)","key":"10.1016\/j.seizure.2016.11.001_bib0180","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1553-2712.2010.00751.x","article-title":"Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis","volume":"17","author":"McMullan","year":"2010","journal-title":"Acad Emerg Med"},{"issue":"August (8)","key":"10.1016\/j.seizure.2016.11.001_bib0185","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/0883073809332768","article-title":"Management of prolonged seizures and status epilepticus in childhood: a systematic review","volume":"24","author":"Sofou","year":"2009","journal-title":"J Child Neurol"},{"issue":"September (9)","key":"10.1016\/j.seizure.2016.11.001_bib0190","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1468-1331.2011.03606.x","article-title":"IV valproate in generalized convulsive status epilepticus: a systematic review","volume":"19","author":"Brigo","year":"2012","journal-title":"Eur J Neurol"},{"issue":"October (Pt A)","key":"10.1016\/j.seizure.2016.11.001_bib0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.yebeh.2016.09.030","article-title":"Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus","volume":"64","author":"Brigo","year":"2016","journal-title":"Epilepsy Behav: E&B"},{"issue":"October (Pt A)","key":"10.1016\/j.seizure.2016.11.001_bib0200","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2016.09.020","article-title":"Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with meta-analysis of randomized controlled trials","volume":"64","author":"Brigo","year":"2016","journal-title":"Epilepsy Behav: E&B"},{"issue":"September (3)","key":"10.1016\/j.seizure.2016.11.001_bib0205","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1684\/epd.2013.0601","article-title":"A common reference-based indirect comparison meta-analysis of intravenous valproate versus intravenous phenobarbitone for convulsive status epilepticus","volume":"15","author":"Brigo","year":"2013","journal-title":"Epileptic Disord"},{"issue":"August","key":"10.1016\/j.seizure.2016.11.001_bib0210","article-title":"Pharmacotherapy for status epilepticus","author":"Trinka","year":"2015","journal-title":"Drugs"},{"issue":"March (4)","key":"10.1016\/j.seizure.2016.11.001_bib0215","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1517\/14656566.2016.1127354","article-title":"Pharmacologic treatment of status epilepticus","volume":"17","author":"Trinka","year":"2016","journal-title":"Expert Opin Pharmacother"},{"issue":"May","key":"10.1016\/j.seizure.2016.11.001_bib0220","article-title":"Efficacy and safety of intravenous valproate for status epilepticus: a systematic review","author":"Trinka","year":"2014","journal-title":"CNS Drugs"},{"issue":"March (3)","key":"10.1016\/j.seizure.2016.11.001_bib0225","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","article-title":"EFNS guideline on the management of status epilepticus in adults","volume":"17","author":"Meierkord","year":"2010","journal-title":"Eur J Neurol"},{"issue":"October (Suppl. 7)","key":"10.1016\/j.seizure.2016.11.001_bib0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/epi.12307","article-title":"Treatment of convulsive status epilepticus in childhood: recommendations of the Italian league against epilepsy","volume":"54","author":"Capovilla","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2016.11.001_bib0235","series-title":"The treatment of epilepsy","first-page":"398","article-title":"Benzodiazepines used in the treatment of epilepsy","author":"Trinka","year":"2015"},{"key":"10.1016\/j.seizure.2016.11.001_bib0240","series-title":"Benzodiazepines II. A handbook. Basic data, analytical methods, pharmacokonetics, and comprehensive literature","author":"Sch\u00fctz","year":"1989"},{"key":"10.1016\/j.seizure.2016.11.001_bib0245","first-page":"487","article-title":"Diazepam versus lorazepam: relationship of drug distribution to duration of clinical action","volume":"vol. 34","author":"Greenblatt","year":"1983"},{"key":"10.1016\/j.seizure.2016.11.001_bib0250","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.1983.03330350028021","article-title":"Double-blind study of lorazepam and diazepam in status epilepticus","volume":"249","author":"Leppik","year":"1983","journal-title":"J Am Med Assoc"},{"issue":"8","key":"10.1016\/j.seizure.2016.11.001_bib0255","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1469-8749.1995.tb15014.x","article-title":"Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus","volume":"37","author":"Appleton","year":"1995","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"10.1016\/j.seizure.2016.11.001_bib0260","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa002141","article-title":"A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus","volume":"345","author":"Alldredge","year":"2001","journal-title":"N Engl J Med"},{"issue":"April (6)","key":"10.1016\/j.seizure.2016.11.001_bib0265","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.2014.2625","article-title":"Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial","volume":"311","author":"Chamberlain","year":"2014","journal-title":"JAMA"},{"issue":"November (230)","key":"10.1016\/j.seizure.2016.11.001_bib0270","article-title":"Making SENSE\u2013Sustained Effort Network for treatment of status epilepticus as a multicenter prospective registry","volume":"15","author":"Kellinghaus","year":"2015","journal-title":"BMC Neurol"},{"issue":"August","key":"10.1016\/j.seizure.2016.11.001_bib0275","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.yebeh.2015.04.010","article-title":"International steering committee of the StEp A. Preliminary results of the global audit of treatment of refractory status epilepticus","volume":"49","author":"Ferlisi","year":"2015","journal-title":"Epilepsy Behav: E&B"},{"issue":"October (Suppl. 8)","key":"10.1016\/j.seizure.2016.11.001_bib0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1528-1167.2011.03237.x","article-title":"Established status epilepticus treatment trial (ESETT)","volume":"52","author":"Cock","year":"2011","journal-title":"Epilepsia"},{"issue":"September (Suppl. 6)","key":"10.1016\/j.seizure.2016.11.001_bib0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/epi.12288","article-title":"The established status epilepticus trial 2013","volume":"54","author":"Bleck","year":"2013","journal-title":"Epilepsia"},{"issue":"July","key":"10.1016\/j.seizure.2016.11.001_bib0290","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.seizure.2016.01.008","article-title":"Intravenous lacosamide in clinical practice-results from an independent registry","volume":"39","author":"Lang","year":"2016","journal-title":"Seizure"},{"issue":"March (3)","key":"10.1016\/j.seizure.2016.11.001_bib0295","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/epi.12058","article-title":"Lacosamide as a new treatment option in status epilepticus","volume":"54","author":"Hofler","year":"2013","journal-title":"Epilepsia"},{"issue":"April (4)","key":"10.1016\/j.seizure.2016.11.001_bib0300","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40263-013-0049-y","article-title":"Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study","volume":"27","author":"Sutter","year":"2013","journal-title":"CNS Drugs"},{"issue":"July","key":"10.1016\/j.seizure.2016.11.001_bib0305","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.yebeh.2014.05.015","article-title":"Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study","volume":"36","author":"Garces","year":"2014","journal-title":"Epilepsy Behav: E&B."},{"issue":"2","key":"10.1016\/j.seizure.2016.11.001_bib0310","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors, and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.seizure.2016.11.001_bib0315","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","article-title":"Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit","volume":"76","author":"Holtkamp","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.seizure.2016.11.001_bib0320","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","article-title":"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review","volume":"43","author":"Claassen","year":"2002","journal-title":"Epilepsia"},{"issue":"August (Pt 8)","key":"10.1016\/j.seizure.2016.11.001_bib0325","first-page":"2314","article-title":"The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy","volume":"135","author":"Ferlisi","year":"2012","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.seizure.2016.11.001_bib0330","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00415-003-0180-7","article-title":"Propofol in status epilepticus: little evidence, many dangers?","volume":"250","author":"Niermeijer","year":"2003","journal-title":"J Neurol"},{"issue":"February (8)","key":"10.1016\/j.seizure.2016.11.001_bib0335","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1212\/WNL.0000000000000009","article-title":"Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study","volume":"82","author":"Sutter","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.seizure.2016.11.001_bib0340","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1528-1157.1995.tb00979.x","article-title":"Neuroprotective effect of ketamine administered after status epilepticus onset","volume":"36","author":"Fujikawa","year":"1995","journal-title":"Epilepsia"},{"issue":"2\u20133","key":"10.1016\/j.seizure.2016.11.001_bib0345","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-1211(00)00175-3","article-title":"Ketamine controls prolonged status epilepticus","volume":"42","author":"Borris","year":"2000","journal-title":"Epilepsy Res"},{"issue":"6","key":"10.1016\/j.seizure.2016.11.001_bib0350","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.410380609","article-title":"Experimental status epilepticus alters gamma-aminobutyric acid type A receptor function in CA1 pyramidal neurons","volume":"38","author":"Kapur","year":"1995","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.seizure.2016.11.001_bib0355","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(99)00238-4","article-title":"N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat","volume":"265","author":"Mazarati","year":"1999","journal-title":"Neurosci Lett"},{"issue":"August (8)","key":"10.1016\/j.seizure.2016.11.001_bib0360","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/epi.12247","article-title":"Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study","volume":"54","author":"Gaspard","year":"2013","journal-title":"Epilepsia"},{"issue":"July (1\u20132)","key":"10.1016\/j.seizure.2016.11.001_bib0365","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2013.01.007","article-title":"Ketamine use in the treatment of refractory status epilepticus","volume":"105","author":"Synowiec","year":"2013","journal-title":"Epilepsy Res"},{"issue":"April (4)","key":"10.1016\/j.seizure.2016.11.001_bib0370","first-page":"e44","article-title":"Drug-induced EEG pattern predicts effectiveness of ketamine in treating refractory status epilepticus","volume":"56","author":"Basha","year":"2015","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.seizure.2016.11.001_bib0375","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/qjmed\/89.12.913","article-title":"Diagnosis and treatment of status epilepticus on a neurological intensive care unit","volume":"89","author":"Walker","year":"1996","journal-title":"QJM"},{"issue":"July (3)","key":"10.1016\/j.seizure.2016.11.001_bib0380","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00008506-199707000-00012","article-title":"Electrographic tachyphylaxis to etomidate and ketamine used for refractory status epilepticus controlled with isoflurane","volume":"9","author":"Kofke","year":"1997","journal-title":"J Neurosurg Anesthesiol"},{"issue":"1","key":"10.1016\/j.seizure.2016.11.001_bib0385","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1525-5050(02)00643-1","article-title":"Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity","volume":"4","author":"Ubogu","year":"2003","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.seizure.2016.11.001_bib0390","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/NCC:4:1:035","article-title":"Literature review, case report, and expert discussion of prolonged refractory status epilepticus","volume":"4","author":"Robakis","year":"2006","journal-title":"Neurocrit Care"},{"issue":"December (2\u20133)","key":"10.1016\/j.seizure.2016.11.001_bib0395","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.eplepsyres.2008.08.005","article-title":"Ketamine successfully terminates malignant status epilepticus","volume":"82","author":"Pruss","year":"2008","journal-title":"Epilepsy Res"},{"issue":"November (9)","key":"10.1016\/j.seizure.2016.11.001_bib0400","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.seizure.2011.06.001","article-title":"Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient","volume":"20","author":"Yeh","year":"2011","journal-title":"Seizure"},{"issue":"April (2)","key":"10.1016\/j.seizure.2016.11.001_bib0405","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12028-011-9668-7","article-title":"Early ketamine to treat refractory status epilepticus","volume":"16","author":"Kramer","year":"2012","journal-title":"Neurocrit care"},{"issue":"August (1)","key":"10.1016\/j.seizure.2016.11.001_bib0410","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12028-013-9858-6","article-title":"Ketamine for medically refractory status epilepticus after elective aneurysm clipping","volume":"19","author":"Zeiler","year":"2013","journal-title":"Neurocrit Care"},{"issue":"May (5)","key":"10.1016\/j.seizure.2016.11.001_bib0415","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/0972-5229.156484","article-title":"Intravenous ketamine for treatment of super-refractory convulsive status epilepticus with septic shock: a report of two cases","volume":"19","author":"Shrestha","year":"2015","journal-title":"Indian J Crit Care Med"},{"issue":"May (3)","key":"10.1016\/j.seizure.2016.11.001_bib0420","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/WNF.0b013e3181d1e3cd","article-title":"Terminating prolonged refractory status epilepticus using ketamine","volume":"33","author":"Hsieh","year":"2010","journal-title":"Clin Neuropharmacol"},{"issue":"February (2)","key":"10.1016\/j.seizure.2016.11.001_bib0425","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/bja\/57.2.197","article-title":"Comparative pharmacology of the ketamine isomers. Studies in volunteers","volume":"57","author":"White","year":"1985","journal-title":"Br J Anaesth"},{"issue":"March (3)","key":"10.1016\/j.seizure.2016.11.001_bib0430","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s001010050546","article-title":"Recovery time after (S)-ketamine or ketamine racemate. Recovery time after short anesthesia in volunteers","volume":"47","author":"Engelhardt","year":"1998","journal-title":"Anaesthesist"},{"issue":"September (9)","key":"10.1016\/j.seizure.2016.11.001_bib0435","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40263-016-0371-2","article-title":"(S)-Ketamine in refractory and super-refractory status epilepticus: a retrospective study","volume":"30","author":"Hofler","year":"2016","journal-title":"CNS Drugs"},{"issue":"July (7)","key":"10.1016\/j.seizure.2016.11.001_bib0440","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1528-1167.2011.03109.x","article-title":"Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy","volume":"52","author":"Hanada","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2016.11.001_bib0445","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ane.12100","article-title":"Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist","volume":"197","author":"Rogawski","year":"2013","journal-title":"Acta Beurol Scand Suppl"},{"issue":"August","key":"10.1016\/j.seizure.2016.11.001_bib0450","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.yebeh.2015.04.005","article-title":"Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit","volume":"49","author":"Rohracher","year":"2015","journal-title":"Epilepsy Behav: E&B"},{"issue":"April","key":"10.1016\/j.seizure.2016.11.001_bib0455","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.yebeh.2015.01.036","article-title":"Efficacy of perampanel in refractory nonconvulsive status epilepticus and simple partial status epilepticus","volume":"45","author":"Redecker","year":"2015","journal-title":"Epilepsy Behav: E&B"},{"issue":"September (3)","key":"10.1016\/j.seizure.2016.11.001_bib0460","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s13760-013-0225-3","article-title":"Possible effect of perampanel on focal status epilepticus after generalized tonic-clonic status epilepticus","volume":"114","author":"Rosche","year":"2014","journal-title":"Acta Neurol Belgica"},{"issue":"34","key":"10.1016\/j.seizure.2016.11.001_bib0465","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci"},{"issue":"Suppl. 5","key":"10.1016\/j.seizure.2016.11.001_bib0470","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1528-1167.2005.01022.x","article-title":"GABA synapses and the rapid loss of inhibition to dentate gyrus granule cells after brief perforant-path stimulation","volume":"46","author":"Naylor","year":"2005","journal-title":"Epilepsia"},{"issue":"September (Suppl. 6)","key":"10.1016\/j.seizure.2016.11.001_bib0475","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/epi.12289","article-title":"Neuroactive steroids for the treatment of status epilepticus","volume":"54","author":"Rogawski","year":"2013","journal-title":"Epilepsia"},{"issue":"December (6)","key":"10.1016\/j.seizure.2016.11.001_bib0480","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ana.24295","article-title":"Pediatric super-refractory status epilepticus treated with allopregnanolone","volume":"76","author":"Broomall","year":"2014","journal-title":"Ann Neurol"},{"issue":"October (Pt 10)","key":"10.1016\/j.seizure.2016.11.001_bib0485","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"issue":"May (Suppl. 3)","key":"10.1016\/j.seizure.2016.11.001_bib0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1167.2011.03028.x","article-title":"The pivotal role of immunity and inflammatory processes in epilepsy is increasingly recognized: introduction","volume":"52","author":"Vezzani","year":"2011","journal-title":"Epilepsia"},{"issue":"April (4)","key":"10.1016\/j.seizure.2016.11.001_bib0495","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131116301996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131116301996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:49:07Z","timestamp":1761011347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131116301996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":99,"alternative-id":["S1059131116301996"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2016.11.001","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"25 years of advances in the definition, classification and treatment of status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2016.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}